Literature DB >> 26550830

Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories.

Pawel Tacik1, Monica Sanchez-Contreras, Rosa Rademakers, Dennis W Dickson, Zbigniew K Wszolek.   

Abstract

BACKGROUND: Tauopathies are a group of neurodegenerative disorders characterized by the pathological accumulation of hyperphosphorylated and insoluble tau protein within neurons and glia. Although most cases are sporadic, hereditary tauopathies have also been reported.
SUMMARY: In this article, we review genetic disorders in which tau pathology has been reported and present two novel families with primary tauopathies. Mutations in the microtubule-associated protein tau gene (MAPT) cause a small subset of primary tauopathies. Mutations in 21 other genes and an 18q deletion syndrome have also been reported to be associated with tau pathology reminiscent of Alzheimer's disease, corticobasal degeneration, progressive supranuclear palsy, argyrophilic grain disease or Pick's disease. In 8 of the 21 genes, tau pathology was only seen in cases with some 'specific' mutations. In the remaining genes, tau pathology, often in the form of Alzheimer-type neurofibrillary lesions, was a common finding but was 'not mutation specific'. The probands of the two families were diagnosed with progressive supranuclear palsy based on clinicopathological evaluation. Their family histories were relevant for parkinsonism in 3 siblings of family 1 and 1 brother and the father from family 2, but these were not autopsy-confirmed. DNA from the brains of the probands from these families was screened for MAPT and leucine-rich repeat kinase 2 gene mutations, but no mutations were identified. KEY MESSAGES: MAPT mutations are a cause of familial tauopathies, but other genes have also been associated with tau pathology. Novel genes still await discovery.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26550830      PMCID: PMC4674317          DOI: 10.1159/000440840

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  34 in total

1.  LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP.

Authors:  Cleanthe Spanaki; Helen Latsoudis; Andreas Plaitakis
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 2.  Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).

Authors:  Dennis W Dickson; Naomi Kouri; Melissa E Murray; Keith A Josephs
Journal:  J Mol Neurosci       Date:  2011-07-01       Impact factor: 3.444

3.  A second case of Gerstmann-Sträussler-Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient.

Authors:  Casper Jansen; Piero Parchi; Sabina Capellari; Rosaria Strammiello; Elise G P Dopper; John C van Swieten; Wouter Kamphorst; Annemieke J M Rozemuller
Journal:  J Neuropathol Exp Neurol       Date:  2011-08       Impact factor: 3.685

Review 4.  Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.

Authors:  Lars M Ittner; Jürgen Götz
Journal:  Nat Rev Neurosci       Date:  2010-12-31       Impact factor: 34.870

5.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology.

Authors:  J B Leverenz; C E Yu; T J Montine; E Steinbart; L M Bekris; C Zabetian; L K Kwong; V M-Y Lee; G D Schellenberg; T D Bird
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

6.  Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2.

Authors:  R L Neve; P Harris; K S Kosik; D M Kurnit; T A Donlon
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

7.  Progressive supranuclear palsy and tau hyperphosphorylation in a patient with a C212Y parkin mutation.

Authors:  Marina P Sánchez; Isabel Gonzalo; Jesús Avila; Justo García De Yébenes
Journal:  J Alzheimers Dis       Date:  2002-10       Impact factor: 4.472

8.  Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.

Authors:  Andrew King; Safa Al-Sarraj; Claire Troakes; Bradley N Smith; Satomi Maekawa; Mariangela Iovino; Maria Grazia Spillantini; Christopher E Shaw
Journal:  Acta Neuropathol       Date:  2012-09-28       Impact factor: 17.088

Review 9.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

Review 10.  Genetics of Progressive Supranuclear Palsy.

Authors:  Sun Young Im; Young Eun Kim; Yun Joong Kim
Journal:  J Mov Disord       Date:  2015-09-10
View more
  13 in total

Review 1.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

Review 2.  A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment.

Authors:  Brati Das; Riqiang Yan
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

3.  Novel Brain-Penetrating Single Chain Antibodies Directed Against 3RTau for the Treatment of Alzheimer's Disease and Related Dementias.

Authors:  Brian Spencer; Robert A Rissman; Cassia Overk; Eliezer Masliah
Journal:  Methods Mol Biol       Date:  2022

4.  Patterns of neuronal Rhes as a novel hallmark of tauopathies.

Authors:  Alexander J Ehrenberg; Kun Leng; Kaitlyn N Letourneau; Israel Hernandez; Caroline Lew; William W Seeley; Salvatore Spina; Bruce Miller; Helmut Heinsen; Martin Kampmann; Kenneth S Kosik; Lea T Grinberg
Journal:  Acta Neuropathol       Date:  2021-03-07       Impact factor: 17.088

Review 5.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

Review 6.  Frontotemporal dementia as a comorbidity to idiopathic normal pressure hydrocephalus (iNPH): a short review of literature and an unusual case.

Authors:  V E Korhonen; E Solje; N M Suhonen; T Rauramaa; R Vanninen; A M Remes; V Leinonen
Journal:  Fluids Barriers CNS       Date:  2017-04-19

7.  Involvement of Oligodendrocytes in Tau Seeding and Spreading in Tauopathies.

Authors:  Isidro Ferrer; Meritxell Aguiló García; Margarita Carmona; Pol Andrés-Benito; Benjamin Torrejón-Escribano; Paula Garcia-Esparcia; José Antonio Del Rio
Journal:  Front Aging Neurosci       Date:  2019-05-28       Impact factor: 5.750

8.  Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders.

Authors:  Brian Spencer; Sven Brüschweiler; Marco Sealey-Cardona; Edward Rockenstein; Anthony Adame; Jazmin Florio; Michael Mante; Ivy Trinh; Robert A Rissman; Robert Konrat; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2018-06-14       Impact factor: 17.088

Review 9.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

10.  Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice.

Authors:  Ramona Belfiore; Alexis Rodin; Eric Ferreira; Ramon Velazquez; Caterina Branca; Antonella Caccamo; Salvatore Oddo
Journal:  Aging Cell       Date:  2018-11-28       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.